Clinical Trial Update: GT201 Injection in Combination with Teraplizumab Injection for Treatment of Patients with Non-small Cell Lung Cancer [NA]

View source ↗

Summary

This clinical trial update reports a study of GT201 Injection in combination with Teraplizumab Injection for non-small cell lung cancer, with the trial currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• GT201 Injection (GT201)
• Teraplizumab Injection (Teraplizumab)

Snippet

Sponsor: Grit Biotechnology | Conditions: Adult, Non-small Cell Lung Cancer | NA | Status: RECRUITING